Beste apotheek van Nederland

Curran M, Keating G. Tadalafil.[erratum appears in Drugs.
2003;63(23):2703]. [Review] [31 refs]. Drugs
2003;63(20):2203-2212.
Curri S B, Menchini Fabris F. Evidence and results obtained
with a new Trans-Epidermal Barrier (T.E.B.) drug in the
medical treatment of vascular impotence. Boll Chim Farm
1996;135(5):316-334.
Cyranoski D. Malaysian researchers bet big on home-grown
Viagra. Nat Med 2005;11(9):912
Czuriga I, Riecansky I, Bodnar J et al. Comparison of the New
Cardioselective Beta-Blocker Nebivolol with Bisoprolol in
Hypertension: The Nebivolol, Bisoprolol Multicenter Study
(NEBIS). Cardiovascular Drugs & Therapy 2003;17(3):257-263.
Dang G, Matern R, Bivalacqua T J et al. Intralesional interferonalpha-2B
injections for the treatment of Peyronie's disease.
South Med J 2004;97(1):42-46.
Davis B E, Weigel J W, Whitford C S. Treatment of male
impotence: a new option. Kans Med 1990;91(12):325-326.
Davis J M. American College of Neuropsychopharmacology ­
43rd annual meeting. 12-16 December 2004, San Juan, Puerto
Rico. IDrugs 2005;8(2):100-103.
Davis M E, Brewster M E. Cyclodextrin-based pharmaceutics:
Past, present and future. Nat Rev Genet 2004;3(12):1023-1035.
De Meyer J M, Oosterlinck W. Influence of the method of
intracavernous injection on penile rigidity: a possible
pharmacokinetic explanation. Urology 1997;49(2):248-252.
De Tejada I. Vardenafil Duration of Action. Eur Urol
2006;50(5):901-902.
De Tejada I, Garvey D S, Schroeder J D et al. Design and
evaluation of nitrosylated alpha-adrenergic receptor antagonists
as potential agents for the treatment of impotence. Journal of
Pharmacology & Experimental Therapeutics 1999;290(1):121­
128.
Degirmenci B, Acar M, Albayrak R et al. Effects of sildenafil
citrate (Viagra) on renal arteries: An evaluation with Doppler
ultrasound. Urol Int 2006;77(2):170-172.
Del Popolo G, Li Marzi V, Mondaini N et al. Time/duration
effectiveness of sildenafil versus tadalafil in the treatment of
erectile dysfunction in male spinal cord-injured patients. Proc
Annu Clin Spinal Cord Inj Conf 2004;42(11):643-648.
Delizonna L L, Wincze J P, Litz B T et al. A comparison of
subjective and physiological measures of mechanically produced
and erotically produced erections (or, is an erection an
erection?). J Sex Marital Ther 2001;27(1):21-31.
Denisov M F, Davis J M, Brecher M. Re: Prolactin levels and
adverse events in patients treated with risperidone [8] (multiple
letters). J Clin Psychopharmacol 2002;22(5):538-540.
Derby C A, Araujo A B, Johannes C B et al.
Measurement of erectile dysfunction in populationbased
studies: the use of a single question selfassessment
in the Massachusetts Male Aging Study.
Int J Impot Res 2000;12(4):197-204.
Derby C A, Barbour M M, Hume A L et al. Drug
therapy and prevalence of erectile dysfunction in the
Massachusetts Male Aging Study cohort.
Pharmacotherapy 2001;21(6):676-683.
Derouet H, Nolden W, Jost W H et al. Treatment of
erectile dysfunction by an external ischiocavernous
muscle stimulator. Eur Urol 1998;34(4):355-359.
Desouza C, Parulkar A, Lumpkin D et al. Acute and
prolonged effects of sildenafil on brachial artery flowmediated
dilatation in type 2 diabetes.. Diabetes Care
2002;25(8):1336-1339.
Dietzen C J, Lloyd L K. Complications of
intracavernous injections and penile prostheses in
spinal cord injured men. Archives of Physical
Medicine & Rehabilitation 1992;73(7):652-655.
Dinelli N, Salinitri G, Pomara G et al. Role of
pharmacologic rehabilitation in the recovery of sexual
function following radical prostatectomy. Minerva
Urol Nefrol 2005;57(4):325-329.
Dinsmore W W. Medical treatment of impotence with
papaverine and phentolamine intracavernosal
injection. Ulster Med J 1990;59(2):174-176.
Dinsmore W W, Gingell C, Hackett G et al. Treating
men with predominantly nonpsychogenic erectile
dysfunction with intracavernosal vasoactive intestinal
polypeptide and phentolamine mesylate in a novel
auto-injector system: a multicentre double-blind
placebo-controlled study. BJU Int 1999;83(3):274­
279.
Djavan B, Milani S, Fong Y K. Dutasteride: A novel
dual inhibitor of 5a-reductase for benign prostatic
hyperplasia. Expert Opin Pharmacother
2005;6(2):311-317.
Doggrell S A. Comparison of clinical trials with
sildenafil, vardenafil and tadalafil in erectile
dysfunction. Expert Opin Pharmacother 2005;6(1):75­
84.
Donatucci C F, Lue T F. Erectile dysfunction in men
under 40: etiology and treatment choice. Int J Impot
Res 1993;5(2):97-103.
Doumas M, Tsakiris A, Douma S et al. Beneficial
effects of switching from beta-blockers to nebivolol
on the erectile function of hypertensive patients. Asian
J Androl 2006;8(2):177-182.
D-63